Showing results (1281-1290 of 1,376) with videos related to
Sort By:
Pageof 138
Immunity|September 13, 2016
HIV Vaccine Design to Target Germline Precursors of Glycan-Dependent Broadly Neutralizing AntibodiesJon M Steichen, Daniel W Kulp, Talar Tokatlian, et al.Plos Pathogens|November 27, 2013
The effects of somatic hypermutation on neutralization and binding in the PGT121 family of broadly neutralizing HIV antibodiesDevin Sok, Uri Laserson, Jonathan Laserson, et al.Immunity|March 8, 2023
Broadly neutralizing anti-S2 antibodies protect against all three human betacoronaviruses that cause deadly diseasePanpan Zhou, Ge Song, Hejun Liu, et al.Science (New York, N.Y.)|January 26, 2021
Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibodyC Garrett Rappazzo, Longping V Tse, Chengzi I Kaku, et al.Nature Genetics|February 9, 2010
Common variants near TERC are associated with mean telomere lengthVeryan Codd, Massimo Mangino, Pim van der Harst, et al.American Journal of Epidemiology|June 6, 2009
Genome-wide association studies, field synopses, and the development of the knowledge base on genetic variation and human diseasesMuin J Khoury, Lars Bertram, Paolo Boffetta, et al.Nature Microbiology|November 15, 2016
An HIV-1 antibody from an elite neutralizer implicates the fusion peptide as a site of vulnerabilityMarit J van Gils, Tom L G M van den Kerkhof, Gabriel Ozorowski, et al.Immunity|August 20, 2022
Antibodies from primary humoral responses modulate the recruitment of naive B cells during secondary responsesJeroen M J Tas, Ja-Hyun Koo, Ying-Cing Lin, et al.Nature Communications|September 6, 2022
Molecular insights into antibody-mediated protection against the prototypic simian immunodeficiency virusFangzhu Zhao, Zachary T Berndsen, Nuria Pedreño-Lopez, et al.Nature Chemical Biology|September 29, 2022
Targeted protein S-nitrosylation of ACE2 inhibits SARS-CoV-2 infectionChang-Ki Oh, Tomohiro Nakamura, Nathan Beutler, et al.Pageof 138